Results of the Abbott RealTime HIV-1 Assay for Specimens Yielding "target Not Detected" Results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 2010 Jan 1

PMID 20042629

Citations 1

Authors

N Esther Babady

Jeffrey J Germer

Joseph D C Yao

Affiliations

Soon will be listed here.

Abstract

No significantly discordant results were observed between the Abbott RealTime HIV-1 assay and the COBAS AmpliPrep/COBAS TaqMan HIV-1 Test (CTM) among 1,190 unique clinical plasma specimens obtained from laboratories located in 40 states representing all nine U.S. geographic regions and previously yielding "target not detected" results by CTM.

Citing Articles

Increased risk of virologic rebound in patients on antiviral therapy with a detectable HIV load <48 copies/mL.

Henrich T, Wood B, Kuritzkes D PLoS One. 2012; 7(11):e50065.

PMID: 23166820 PMC: 3499490. DOI: 10.1371/journal.pone.0050065.

References

Brennan C, Stramer S, Holzmayer V, Yamaguchi J, Foster G, Notari Iv E . Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains in United States blood donors. Transfusion. 2008; 49(1):125-33. DOI: 10.1111/j.1537-2995.2008.01935.x. View

Damond F, Roquebert B, Benard A, Collin G, Miceli M, Yeni P . Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J Clin Microbiol. 2007; 45(10):3436-8. PMC: 2045351. DOI: 10.1128/JCM.00973-07. View

Sloma C, Germer J, Gerads T, Mandrekar J, Mitchell P, Yao J . Comparison of the Abbott realtime human immunodeficiency virus type 1 (HIV-1) assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 test: workflow, reliability, and direct costs. J Clin Microbiol. 2009; 47(4):889-95. PMC: 2668302. DOI: 10.1128/JCM.02231-08. View

Colson P, Solas C, Moreau J, Motte A, Henry M, Tamalet C . Impaired quantification of plasma HIV-1 RNA with a commercialized real-time PCR assay in a couple of HIV-1-infected individuals. J Clin Virol. 2007; 39(3):226-9. DOI: 10.1016/j.jcv.2007.04.007. View

Rayfield M, Sullivan P, Bandea C, Britvan L, Otten R, Pau C . HIV-1 group O virus identified for the first time in the United States. Emerg Infect Dis. 1996; 2(3):209-12. PMC: 2626795. DOI: 10.3201/eid0203.960307. View

Sides T, Akinsete O, Henry K, Wotton J, Carr P, Bartkus J . HIV-1 subtype diversity in Minnesota. J Infect Dis. 2005; 192(1):37-45. DOI: 10.1086/430322. View

Gueudin M, Plantier J, Lemee V, Schmitt M, Chartier L, Bourlet T . Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr. 2007; 44(5):500-5. DOI: 10.1097/QAI.0b013e31803260df. View

Achkar J, Burda S, Konings F, Urbanski M, Williams C, Seifen D . Infection with HIV type 1 group M non-B subtypes in individuals living in New York City. J Acquir Immune Defic Syndr. 2004; 36(3):835-44. DOI: 10.1097/00126334-200407010-00011. View

Amendola A, Milia M, Ghisetti V, Brega C, Zaccaro P, Capobianchi M . Accuracy of a commercial real-time polymerase chain reaction-based system for measurement of HIV RNA levels around the limit of quantification of the assay. Clin Infect Dis. 2009; 48(11):1630-1. DOI: 10.1086/598990. View

10.

Korn K, Weissbrich B, Henke-Gendo C, Heim A, Jauer C, Taylor N . Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay. J Clin Microbiol. 2009; 47(4):1238-40. PMC: 2668364. DOI: 10.1128/JCM.02204-08. View

11.

Manavi K . The significance of low-level plasma HIV viral load on COBAS TaqMan HIV-1 assays for patients with undetectable plasma viral load on COBAS Amplicor monitor version 1.5. HIV Clin Trials. 2008; 9(4):283-6. DOI: 10.1310/hct0904-283. View

12.

Lee P, Kieffer T, Siliciano R, Nettles R . HIV-1 viral load blips are of limited clinical significance. J Antimicrob Chemother. 2006; 57(5):803-5. DOI: 10.1093/jac/dkl092. View

13.

Nettles R, Kieffer T, Kwon P, Monie D, Han Y, Parsons T . Intermittent HIV-1 viremia (Blips) and drug resistance in patients receiving HAART. JAMA. 2005; 293(7):817-29. DOI: 10.1001/jama.293.7.817. View

14.

Wolff D, Gerritzen A . Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott RealTime Test assays for quantification of hepatitis C virus and HIV RNA. Clin Chem Lab Med. 2007; 45(7):917-22. DOI: 10.1515/CCLM.2007.149. View